Pharmaceutical market in Vietnam has potential but remains chaotic and poorly regulated
Research and Markets (http://www.researchandmarkets.com/reports/c44605) has announced the addition of Espicom Business Intelligence’s new report: The Pharmaceutical Market: Vietnam to their offering.
Vietnam’s pharmaceutical market remains chaotic and poorly regulated.
Despite steady market growth and rising per capita consumption in recent years, Vietnam’s pharmaceutical market remains chaotic and poorly regulated, with enforcement of IP, distribution and dispensing laws a major problem. The country has a large number of small manufacturers, which often produce copied drugs of poor quality. The Vietnamese government has produced a compulsory GMP licensing system, although enforcing this appears to be an equally difficult task. For outsiders, trade practices in general are among the most restrictive and bureaucratic in the region.
The market is still worth considering, however. The opening of the economy since the doi moi reforms of the mid-1980s has created a demand for Western drugs which cannot be met by the local industry. Imports, therefore, comprise a significant proportion of the market by value. European suppliers dominate, with the French at the forefront, due to their long historical ties with the region. US manufacturers have only been able to directly supply Vietnam since the lifting of the US government trade boycott in 1994.
The healthcare system in Vietnam is partly funded through a national health insurance scheme, which is compulsory for all industrial workers and government employees. However, the system is far from comprehensive. As of the end of 2003, only 14% of employed people had social insurance and 21% had health insurance.
These in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
1. Executive Summary
2. Pharmaceutical Market
3. Key National Data Projections
4. Geography
5. Political Overview
6. Economic Overview
7. Population
8. Demographic Indicators
9. Mortality
10. Morbidity
11. Organisation & Administration
12. Health Expenditure
13. Hospital Services
14. Ambulatory Care
15. Medical Personnel
16. Regulatory Environment
17. Distribution Channels
18. Pharmaceutical Imports
19. Domestic Production & Exports
20. directory
For more information visit http://www.researchandmarkets.com/reports/c44605
Source: Datamonitor
Contact:
Research and Markets
Laura Wood
Fax: +353 1 4100 980
press@researchandmarkets.com
Source: Research and Markets
Category: Health
